Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007278:Injections, Spinal; D008578:Meninges; D009369:Neoplasms / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D013852:Thiotepa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D013852:Thiotepa